Table 1.
PGF2α | C-1 | C-2 | C-3 | C-4 | C-5 | C-6 | C-7 | C-8 | C-9 | C-10 |
---|---|---|---|---|---|---|---|---|---|---|
15R | 177.05 | 32.7 | 24.45 | 26.11 | 129.59 | 129.08 | 24.99 | 50.99 | 72.63 | 42.96 |
15S | 177.37 | 32.91 | 24.45 | 26.24 | 129.58 | 129.13 | 25.22 | 50.20 | 72.49 | 42.69 |
15R − 15S | −0.32 | −0.21 | 0 | −0.13 | 0.01 | −0.05 | −0.23 | 0.79 | 0.14 | 0.27 |
C-11 | C-12 | C-13 | C-14 | C-15 | C-16 | C-17 | C-18 | C-19 | C-20 | |
15R | 77.87 | 55.65 | 132.4 | 134.59 | 72.96 | 37.05 | 25.13 | 31.7 | 22.61 | 14.03 |
15S | 77.61 | 55.34 | 132.61 | 134.95 | 73.13 | 36.87 | 25.22 | 31.7 | 22.61 | 14.03 |
15R − 15S | 0.26 | 0.31 | −0.21 | −0.36 | −0.17 | 0.18 | −0.09 | 0 | 0 | 0 |
A comparison of the chemical shifts from separate measurements cannot be taken as decisive because of very strong solvent and concentration effects in the 13C NMR spectra of prostaglandins. These dilution effects account for the slight differences between our observations and an earlier report of 13C NMR differences for 15R- and 15S-PGF2α (20).